Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
FXI vs XLV: how they differ
FXI and XLV hold 0% of their weight in the same names, and XLV returned more over the year.
iShares China Large-Cap ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, FXI and XLV hold 0% of their money in the same securities at the same weight.
| Only in FXI | Only in XLV |
|---|---|
| Alibaba Group Holding Limited 8.66% | Eli Lilly & Co 16.56% |
| CHINA CONSTRUCTION BANK CORPORATION 8.25% | Johnson & Johnson 10.67% |
| Tencent Holdings Limited 7.72% | AbbVie Inc 7.76% |
| INDUSTRIAL AND COMMERCIAL BANK OF CHINA 6.02% | UnitedHealth Group Inc 6.59% |
| XIAOMI CORPORATION 5.41% | Merck & Co Inc 5.54% |
| MEITUAN 4.79% | Amgen Inc 3.41% |
| Ping An Insurance (Group) Company of Chi 4.41% | Thermo Fisher Scientific Inc 3.25% |
| BYD COMPANY LIMITED 4.09% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| FXI iShares China Large-Cap ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | China Large-Cap | Health care |
| Total return, 1 year | −13.8% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −31.3 pts | +2.9 pts |
| Expense ratio | 0.73% | 0.08% |
| Already in the S&P 500 | 0.0% | 100.0% |
| Holdings | 52 | 59 |
FXI in plain words
FXI is an index equity fund tracking the China Large-Cap. Over the year to Sep 11, 2026 it returned −13.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.73% a year. By its holdings filed for Apr 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 52 positions, with the top ten at 56.6%. It sat 28.5% below its high of Feb 17, 2021 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, FXI or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, FXI returned −13.8% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, FXI or XLV?
- FXI charges 0.73% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do FXI and XLV overlap with the S&P 500?
- By their latest filed holdings, 0% of FXI and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FXI against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/FXI-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources